Lung Cancer - Radiation Therapy

Podcast

The Atrium: Neoadjuvant Chemoimmunotherapy

September 29, 2026 | Alice Copperwheat…

In this episode of The Atrium, host Alice Copperwheat speaks with Jessica Donington, Professor of Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago, Illinois, USA, about neoadjuvant chemoimmunotherapy. The...

Podcast

The Atrium: Neoadjuvant Chemoimmunotherapy

September 29, 2026 | Alice Copperwheat…

In this episode of The Atrium, host Alice Copperwheat speaks with Jessica Donington, Professor of Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago, Illinois,...

JANS Article

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

November 10, 2023 | Aristotle ProtopapasGold ContributorGold Commentor

A manuscript that wil certainly be discussed in lung MDT! The thought of a RCT in these earlier stages may be already in the mind of the sponsors… The authors...

JANS Article

Personalized Magnetic Tentacles for Targeted Photothermal Cancer Therapy in Peripheral Lungs

October 12, 2023 | Jason TrevisBronze Contributor

Lung cancer has the highest worldwide cancer mortality rate. Early non-small cell lung cancer accounts for 84 percent of cases, with curative surgical intervention being the standard treatment. The authors...

JANS Article

The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and Multidisciplinary Management of Patients with Early-Stage Non-Small Cell Lung Cancer

June 15, 2023 | Cameron LindGold Contributor

A new expert consensus on diagnosis, staging, and therapy for early-stage non-small cell lung cancer patients has been released. The experts recommend CT and PET imaging as a necessary part...

JANS Article

Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base

April 13, 2018 | Mark FergusonGold Contributor

The authors found that adjuvent chemoradiotherapy after resection of N2 NSCLC was more effective if given sequentially than concomitantly.

...
JANS Article

In Global News: Smallest Heart Valve for Infants, a Modified TAVR Valve for TMVR, and Thoracic Outlet Surgery Fashion

March 9, 2018 | Claire VernonGold Contributor

Patient Care Carter Capps, a pitcher for professional baseball team the San Diego Padres, has made himself a necklace out of the rib surgeons removed during his thoracic outlet surgery....

Video

Surgery and Advances in Competing Technology

March 8, 2018 | Eric Lim

Eric Lim of the Royal Brompton Hospital in London, UK, discusses the future of general thoracic surgery in the context of a rapid rise of competing radiotherapy technology. He demonstrates...

JANS Article

The Great Debate Flashes: Surgery Versus Stereotactic Body Radiotherapy as the Primary Treatment of Early-Stage Lung Cancer

February 26, 2018 | Claire VernonGold Contributor

Weder and colleagues present a debate addressing surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer. Arguments relating to outcome and the impact on further therapy...

JANS Article

VATS Lobectomy Is Associated With Greater Recurrence-Free Survival Than SBRT for Clinical Stage I Lung Cancer

December 14, 2017 | Mark FergusonGold Contributor

Using propensity score matching, patients with clinical stage I NSCLC who underwent either VATS lobectomy or stereotactic body radiotherapy (SBRT) were compared for long-term outcomes. Among 37 matched pairs, tumor...

JANS Article

Narcissus, the Beam, and lung cancer

June 11, 2016 | Mark FergusonGold Contributor

The author describes the growing role of SBRT in lung cancer therapy and the growing role of radiation oncologists in decision-making regarding lung cancer. The cautionary note is that surgeons...

JANS Article

Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer

June 4, 2016 | Mark FergusonGold Contributor

The authors used data from the NCDB to assess long-term outcomes after SBRT (1,781) or lobectomy (13,562) for clinical stage I NSCLC in patients without important co-morbidities. Overall survival was...

JANS Article

Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy

January 23, 2016 | Lisa BrownBronze Contributor

Retrospective study of surgery versus SBRT for clinical stage I NSCLC using the National Cancer Data Base (NCDB). Propensity score matching was used to create 5355 matched pairs. In that...

LOAD MORE
ADVERTISE ON CTSNET